CMPD1 inhibited human gastric cancer cell proliferation by inducing apoptosis and G2/M cell cycle arrest
Open Access
- 16 April 2018
- journal article
- research article
- Published by Springer Nature in Biological Research
- Vol. 51 (1) , 11
Abstract
Gastric cancer occupies the fourth highest morbidity rate of cancers worldwide. Clinical therapies of gastric cancer remain limited because of uncertainty of mechanisms and shortness of effective medicine. Thus, new drug candidates for gastric cancer treatment is urgently needed. In this study, CMPD1 as a wildly used MK2 phosphorylation inhibitor was employed to find its impact on gastric cancer cell proliferation, apoptosis and cell cycle using colony formation assay and flow cytometry analysis. Along with its anti-proliferation effect on gastric cancer cell line MKN-45 and SGC7901, CMPD1 also induced massive apoptosis and significant G2/M phase arrest in a time-dependent and dose-dependent manner in MKN-45 cells respectively. Furthermore, Western blot confirmed that the expression of anti-apoptotic proteins Bcl-2 was decreased while BAX, cytochrome c release and cleaved PARP were increased. In addition, oncogene c-Myc was downregulated in response to CMPD1 treatment. Our results demonstrated that CMPD1 has anti-tumor effect on human gastric cancer cell line MKN-45 possibly via downregulating oncogene c-Myc expression and CMPD1 could be applied as a potential candidate for treating gastric malignancy. To the best of our knowledge, it is the first report of anti-tumor effect of CMPD-1 on human gastric cancer cells.Keywords
Funding Information
- Natural Science Foundation of Anhui Province (1508085MH146)
This publication has 45 references indexed in Scilit:
- Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage responseNature Reviews Molecular Cell Biology, 2013
- Mitogen-activated protein kinases in innate immunityNature Reviews Immunology, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replicationProceedings of the National Academy of Sciences, 2010
- Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cellsLeukemia, 2009
- Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2Current Opinion in Cell Biology, 2009
- G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancerBritish Journal of Cancer, 2008
- Suppression of C-myc Expression Associates with Anti-Proliferation of Aloe-Emodin on Gastric Cancer CellsCancer Investigation, 2008
- p53-Deficient Cells Rely on ATM- and ATR-Mediated Checkpoint Signaling through the p38MAPK/MK2 Pathway for Survival after DNA DamageCancer Cell, 2007
- Clonogenic assay of cells in vitroNature Protocols, 2006